These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 37043848)
1. Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops. Nielsen S; Barratt M; Hiley S; Bartlett M; Latimer J; Jauncey M; Roux C; Morelato M; Clark N; Kowalski M; Gilbert M; Francia L; Shipton A; Gerostamoulos D; Glowacki L; Lam T Int J Drug Policy; 2023 May; 115():104015. PubMed ID: 37043848 [TBL] [Abstract][Full Text] [Related]
2. Infrequent detection of unintentional fentanyl use via urinalysis among people who regularly inject opioids in Sydney and Melbourne, Australia. Lam T; Barratt MJ; Bartlett M; Latimer J; Jauncey M; Hiley S; Clark N; Gerostamoulos D; Glowacki L; Roux C; Morelato M; Nielsen S Addiction; 2022 Aug; 117(8):2331-2337. PubMed ID: 35129225 [TBL] [Abstract][Full Text] [Related]
3. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Lockwood TE; Vervoordt A; Lieberman M Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405 [TBL] [Abstract][Full Text] [Related]
4. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493 [TBL] [Abstract][Full Text] [Related]
5. Urine drug screening for early detection of unwitting use of fentanyl and its analogues among people who inject heroin in Sydney, Australia. Barratt MJ; Latimer J; Jauncey M; Tay E; Nielsen S Drug Alcohol Rev; 2018 Nov; 37(7):847-850. PubMed ID: 30289187 [TBL] [Abstract][Full Text] [Related]
6. The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia. Roxburgh A; Livingston M; Dietze P; Nielsen S; Cogger S; Bartlett M; Day C; Latimer J; Jauncey M; Clark N Public Health; 2023 Nov; 224():90-97. PubMed ID: 37742585 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991 [TBL] [Abstract][Full Text] [Related]
8. "You can't go wrong being safe": Motivations, patterns, and context surrounding use of fentanyl test strips for heroin and other drugs. Reed MK; Guth A; Salcedo VJ; Hom JK; Rising KL Int J Drug Policy; 2022 May; 103():103643. PubMed ID: 35255392 [TBL] [Abstract][Full Text] [Related]
9. "If I had them, I would use them every time": Perspectives on fentanyl test strip use from people who use drugs. Reed MK; Salcedo VJ; Guth A; Rising KL J Subst Abuse Treat; 2022 Sep; 140():108790. PubMed ID: 35577663 [TBL] [Abstract][Full Text] [Related]
10. Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North Carolina. Zibbell JE; Peiper NC; Duhart Clarke SE; Salazar ZR; Vincent LB; Kral AH; Feinberg J Int J Drug Policy; 2021 Jul; 93():103128. PubMed ID: 33487527 [TBL] [Abstract][Full Text] [Related]
11. Testing the test strips: laboratory performance of fentanyl test strips. Halifax JC; Lim L; Ciccarone D; Lynch KL Harm Reduct J; 2024 Jan; 21(1):14. PubMed ID: 38238757 [TBL] [Abstract][Full Text] [Related]
12. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Salmon AM; van Beek I; Amin J; Kaldor J; Maher L Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs. Park JN; Frankel S; Morris M; Dieni O; Fahey-Morrison L; Luta M; Hunt D; Long J; Sherman SG Int J Drug Policy; 2021 Aug; 94():103196. PubMed ID: 33713964 [TBL] [Abstract][Full Text] [Related]
14. Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals "blind spots" in detection capabilities. Hayes KL; Lieberman M Harm Reduct J; 2023 Dec; 20(1):175. PubMed ID: 38057832 [TBL] [Abstract][Full Text] [Related]
15. Evaluating the sensitivity, stability, and cross-reactivity of commercial fentanyl immunoassay test strips. Rodriguez-Cruz SE J Forensic Sci; 2023 Sep; 68(5):1555-1569. PubMed ID: 37420315 [TBL] [Abstract][Full Text] [Related]
16. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users. Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196 [TBL] [Abstract][Full Text] [Related]
17. Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre. Latimer J; Ling S; Flaherty I; Jauncey M; Salmon AM Int J Drug Policy; 2016 Nov; 37():111-114. PubMed ID: 27750104 [No Abstract] [Full Text] [Related]
18. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking. Tilhou AS; Zaborek J; Baltes A; Salisbury-Afshar E; Malicki J; Brown R Harm Reduct J; 2023 Mar; 20(1):41. PubMed ID: 36978170 [TBL] [Abstract][Full Text] [Related]
19. Pilot testing fentanyl test strip distribution in an emergency department setting: Experiences, lessons learned, and suggestions from staff. Reed MK; Salcedo VJ; Hsiao T; Esteves Camacho T; Salvatore A; Siegler A; Rising KL Acad Emerg Med; 2023 Jun; 30(6):626-635. PubMed ID: 36333960 [TBL] [Abstract][Full Text] [Related]
20. Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Roxburgh A; Hall WD; Dobbins T; Gisev N; Burns L; Pearson S; Degenhardt L Drug Alcohol Depend; 2017 Oct; 179():291-298. PubMed ID: 28826104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]